HD vs KO: Which Is the Better Buy?

Side-by-side comparison of The Home Depot, Inc. and The Coca-Cola Company β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-25.
The Home Depot, Inc. Β· Consumer Cyclical
$292.18
+44.2% upside to fair value
Med Conviction Grade B High Quality
VS
The Coca-Cola Company Β· Consumer Defensive
$88.71
+15.5% upside to fair value
Med Conviction Grade C High Quality
QuantHub Verdict
HD has more upside to fair value (+44.2%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric HD KO
Current Price $292.18 $88.71
Fair Value Estimate $421.26 $102.44
Upside to Fair Value +44.2% +15.5%
Market Cap $291.3B $381.7B
Forward P/E β€” β€”
EV / EBITDA 14.7x 20.8x
Price / Sales 1.7x 7.6x
Price / FCF 19.2x 26.7x
Revenue Growth YoY +5.7% +6.7%
Gross Margin 33.2% 61.9%
Operating Margin 12.4% 29.6%
Return on Equity 102.7% 43.0%
Dividend Yield 3.18% 2.37%
FCF Yield 5.2% 3.75%
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
HD β€” The Home Depot, Inc.
The Home Depot is the largest home-improvement retailer in the United States, operating a network of roughly 2,300 stores supported by about 472,400 full-time employees, and serving both do-it-yourself homeowners and professional contractors through stores, homedepot.com, and specialty sites such as blinds.com. The business quality is high: it generates a 102.7% return on equity, a 33.2% trailing…
KO β€” The Coca-Cola Company
The Coca-Cola Company is a global non-alcoholic beverage concentrate, brand-management and bottling-system business with products sold in more than 200 countries and territories, supported by powerful trademarks, 2.2 billion daily servings and an entrenched distribution network. Business quality is high: TTM gross, operating and net margins are 61.9%, 29.6% and 28.6%, respectively, ROE is 43.0%, …
Accumulation Zones
Metric HD KO
Zone Low $315.94 $76.83
Zone High $358.07 $87.07
In Buy Zone? Yes No
← HD Research    KO Research β†’    All Research